Nu-Med Plus, Inc. (NUMD): Total Liabilities
$279.2K
As of 2025-12-31
$280.4K
As of 2026-06-30
+25.1%
3-year compound annual growth
+25.6%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $279.2K | +24.4% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $224.5K | +40.1% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $160.2K | +12.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $142.6K | -7.7% | 2024-03-26, Balance as of period end |
| 2021-12-31 | $154.5K | +72.8% | 2023-04-03, Balance as of period end |
| 2020-12-31 | $89.4K | -78.5% | 2022-04-11, Balance as of period end |
| 2019-12-31 | $416.2K | +11.1% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $374.5K | +10.6% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $338.5K | -92.4% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $4.47M | n/a | 2018-04-03, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Nu-Med Plus, Inc. (NUMD) | 2025-12-31 | $279.2K | +24.4% |
| RetinalGenix Technologies Inc. (RTGN) | 2025-12-31 | $2.32M | +57.3% |
| ALR Technologies SG Ltd. (ALRTF) | 2025-12-31 | $39.91M | +9.9% |
| Stimcell Energetics Inc. (STME) | 2026-05-31 | $1.89M | +49.3% |
| Global Innovative Platforms Inc. (GIPL) | 2025-09-30 | $11.6K | -65.0% |
| Sigyn Therapeutics, Inc. (SIGY) | 2024-12-31 | $4.67M | +25.1% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $4.92M | +4.9% |
| Mountain Crest Acquisition Corp. V (MCAG) | 2025-12-31 | $3.72M | +3.7% |
| Family Office of America, Inc. (FOFA) | 2025-12-31 | $878.5K | n/m |
Compare NUMD, RTGN, ALRTF, STME side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗